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The cell adhesion molecule neurofascin (NF) has a major neuronal isoform (NF186) containing a mucin-like domain followed by a fifth
fibronectin type III repeat while these domains are absent from glial NF155. Neuronal NF isoforms lacking one or both of these domains are
expressed transiently in embryonic dorsal root ganglia (DRG). These two domains are co-expressed in mature NF186, which peaks in expression
prior to birth and then persists almost exclusively at nodes of Ranvier on myelinated axons. In contrast, glial NF155 is only detected postnatally with
the onset of myelination. All these forms of NF bound homophilically and to Schwann cells but only the mature NF186 isoform inhibits cell
adhesion, and this activity may be important in formation of the node of Ranvier. Schwann cells deficient in NF155 myelinated DRG axons in a
delayed manner and they showed significantly decreased clustering of both NF and Caspr in regions where paranodes normally form. The combined
results suggest that NF186 is expressed prenatally on DRG neurons and it may modulate their adhesive interactions with Schwann cells, which
express NF155 postnatally and require it for development of axon–glial paranodal junctions.
© 2007 Elsevier Inc. All rights reserved.Keywords: Ig CAM; Myelin; Glia; Nerve development; Node of Ranvier; Paranode; Schwann cell; PNSIntroduction
Neurofascin (NF) is a member of the L1 subgroup of the
Ig superfamily that is involved in neurite outgrowth, neurite
fasciculation and the organization of the node of Ranvier at
the earliest stages of development (Brummendorf and
Rathjen, 1995; Koticha et al., 2006; Lambert et al., 1997;
Pruss et al., 2004). NF has domain organization resembling
other members of the Ig superfamily, consisting of six Ig
domains, several fibronectin type III (FnIII) repeats, a single
transmembrane region and a cytoplasmic domain. An unusual
feature of NF among various Ig CAMs is its many
alternatively spliced isoforms that exhibit differential spatio-⁎ Corresponding author. Fax: +1 732 445 2063.
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doi:10.1016/j.ydbio.2007.08.045temporal patterns of expression during development (Hassel
et al., 1997). Two of the major splice variants that display
distinctive patterns of expression during development are
neuronal NF186 containing a mucin-like region followed by a
fifth FnIII repeat and glial NF155 containing a third FnIII
repeat with an integrin binding motif (Davis et al., 1996; Tait
et al., 2000). Despite recent progress in elucidating differ-
ential splicing of NF mRNA during development (Hassel et
al., 1997; Tait et al., 2000), the functions of the different
isoforms and their temporal expression patterns during
development are still poorly understood.
Characterization of the chicken NF gene and its multiple
alternatively spliced isoforms (Hassel et al., 1997) provided a
molecular basis for expression of many differentially expressed
NF isoforms during development. Differential expression of ten
alternatively spliced exons suggested that at least fifty different
NF isoforms could be expressed in chick (Hassel et al., 1997).
Cell type specific regulation in mammals is exemplified by
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Schwann cells and oligodendrocytes (Collinson et al., 1998;
Tait et al., 2000). NF splicing has already been recognized to
function in modulating heterophilic binding to contactin, axonin
and tenascin-R (Pruss et al., 2006, 2004; Volkmer et al., 1998)
and the mucin-like region of NF186 inhibits cell adhesion (Ko-
ticha et al., 2005). Considering the complexity of NF splicing in
the chicken, it is of interest to explore whether similar patterns
of NF isoforms are expressed during mammalian development
and to understand their functions.
NF155 is expressed by myelinating cells in PNS and its
expression is transiently upregulated at the onset of myelino-
genesis in the CNS (Collinson et al., 1998), suggesting that it
may play a role in node formation by oligodendrocytes in CNS
(Tait et al., 2000). NF186 and NrCAM, which are expressed on
neurons (Davis et al., 1996; Tait et al., 2000), bind to ankyrinG
and are clustered at developing nodes of Ranvier in peripheral
axons (Custer et al., 2003; Lambert et al., 1997; Salzer, 2003;
Schafer et al., 2006). NF is involved in early stages of node
formation in peripheral axons and node formation is perturbed
by binding of NF-Fc to gliomedin on Schwann cells in vitro
(Eshed et al., 2005; Koticha et al., 2006). NF knockout studies
in mice indicate that it plays critical roles in axo-glial signaling
and organization of proteins at the node of Ranvier (Sherman et
al., 2005). However, the functions of the various NF isoforms
are still unclear.
In this study, we investigated developmentally regulated
expression patterns and functions of various exons of neuronal
and glial NF in rat PNS. The results indicate complex changes
in neuronal NF mRNA isoforms before birth, and dramatic
upregulation of glial NF mRNA isoforms as myelination
begins postnatally. Structure–function analyses of neuronal NF
isoforms suggests that maximal inhibition of cell adhesion
requires the mucin-like domain, which localizes specifically to
the node of Ranvier and has been proposed to be involved in
node formation. Finally, glial NF has been implicated in
paranodal clustering in co-cultures of Schwann cell with
axons.Table 1
Oligonucleotide primer sets used for Q-PCR
Gene name Forward
Exon 3 TCCAAGCATTCAGAATGAGCTG
Exon 8 CCCTGACATATATAGTGCCCGA
Exon 17 TCCGACTAACCGTTTGGCTG
NF FN1 TTCCAGCCAGGAGTCTTGCAT
NF FN2 ATTGTCAAGTGGCGACGGA
NF FN3 TCAGTGGAACCGCGTCTACTC
NF FN4 TTTCAGAGTCCGACAGCCCAA
NF FN5 TGGAAGCACAATTTCAGGCC
NF Mucin TTCTCCCTCAGTGCCAGGAC
NF Cyto ATGTGTGCCATTGCCCTTCT
MBP GACACGGGCATCCTTGACTC
Gliomedin ACAAACAGAACCCATGATCACG
GAPDH AACTCCCTCAAGATTGTCAGCA
β-Actin CGTAGCCATCCAGGCTGTGT
SCIP TGGTTCCTAGAGCTCGCATCTC
S100β GGGAGAGAGGGTGACAAGCAMaterials and methods
Quantitative real-time PCR (Q-PCR)
Transcripts for various domains of NF186 and NF155 by RT–PCR were
quantitated using Q-PCR. Primer pairs (Table 1) were designed using the ABI
Primer Express software (Applied Biosystems, Foster City, CA) to amplify
specific regions in the NF gene and were synthesized (IDT, Coralville, IA). To
amplify the NF155 isoform alone, a primer pair was designed for the third FnIII
domain of NF gene. To amplify NF186, primers were designed against the
mucin-like domain and the fifth FnIII domain. Total NF expression was
analyzed using primers synthesized against four regions common to all known
isoforms including the first, second, and fourth FnIII domains, and the
cytosolic conserved region. To investigate the exon usage during development
of the PNS, primers were designed for amplification of exons 3 and 17 in
NF186, and the FnIII domain in NF155. To compare the expression of these
NF mRNAs to proteins known to be involved in myelination, additional
primers were designed for amplification of gliomedin (Eshed et al., 2005) and
myelin basic protein (MBP). Briefly, sciatic nerves of postnatal P0–8 pups and
dorsal root ganglions (DRG) from E13, E15, and E18.5 embryos and P2 and P4
pups were dissected and immediately placed into lysis buffer. Total RNA from
these samples were isolated using the RNeasy kit (Qiagen, Valencia, CA) and
RT–PCR reactions were performed according to standard protocol using Taq
Polymerase and the SYBR Green PCR Master Mix (Applied Biosystems,
Foster City, CA). To evaluate the presence of immature or mature Schwann
cells in the samples, we performed RT–PCR for the transcription factor SCIP
(Blanchard et al., 1996) and the calcium binding protein S100β (Aquino et al.,
2006), respectively.
Quantitative expression profiles of glial and neuronal NF were analyzed by
Q-PCR using the same selected gene-specific primer pairs (Table 1). Q-PCR
reactions were performed in a 10 μl volume using SYBR Green PCR Master
Mix in ABI PRISM 7900HT Sequence Detection System (Applied Biosystems,
Foster City, CA). Amplification of β-actin and GAPDH were used to normalize
the expression levels of each sample. Standard curves were generated for each
gene using serial dilution of control cDNA plasmid mixes for full-length
pEGFP-N1-NF155 (a kind gift from Dr. Elior Peles, Weitzmann Institute,
Rehovot, Israel) and pNF186–GFP (Koticha et al., 2005). Finally, a
dissociation step was performed for each reaction to confirm the purity of
amplified products.
To verify neuronal isoforms of NF that contained the mucin and fifth FnIII
domains, primers were designed to amplify the region between the 3′ end of the
fourth FnIII repeat and the middle of the cytoplasmic conserved region (Fig.
1A). The PCR reactions were performed with the Platinum Pfx Polymerase Kit
(Invitrogen, Carlsbad, CA), and run on a 2% agarose gel for analysis of the
products.Reverse
CCTGCTGTTGCGAGTCCAG
CCATGCAATATCTGGTGTTGG
AAACTGGACAACGTAGTCTGTGATG
AACCTCGTTGACAGCGATGAC
CCAAAGTCATTTTCAGCCTGG
ACCACAACCATCTCCAGCTTG
TTCCACCATCTGCTTTCCCAG
AATACACCCGCAACGTGTACG
TGGGATGATGGGAACTGTTGT
GGTGCCGTCCAGAGATGTCT
ACCCCTGTCACCGCTAAAGA
CTCCTTCACCATGATGCCTGA
A GGCTAAGCAGTTGGTGGTGC
CCAGTGGTACGACCAGAGGC
TTCTGAAAGTGCAGCAGGCAC
CACACTCCCCATCCCCATC
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DRGs were dissected from E15 and E18 embryos and incubated in tissue
protection and extraction reagent (T-PER) (Pierce, Rockford, IL). Samples were
briefly sonicated and centrifuged at 20,000×g at 4 °C for 5 min. Total protein in
the supernatant was estimated using the BCAProtein assay kit (Pierce, Rockford,
IL) and equal amounts of protein were electrophoresed on NuPAGENovex Bis–
Tris (Invitrogen, Carlsbad, CA) in 4–12% gradient gels and transferred to
nitrocellulose membranes (Invitrogen, Carlsbad, CA). After blocking, the blots
were incubated overnight at 4 °Cwith primary antibodies and washed three times
in Tris-buffered saline with 0.05% Tween 20 before probing with horseradish
peroxidase conjugated secondary antibodies (Jackson ImmunoResearch, West
Grove, PA) for 1 h at room temperature. Blots were then visualized with
enhanced chemiluminescence reagent (GE Healthcare, Piscataway, NJ). NF
specific antibodies including monoclonal anti-pan-NF antibody (Schafer et al.,2006) and polyclonal anti-mucin antibody were used along with polyclonal anti-
tubulin antibody (Covance, CA, USA) as a control for protein loading. The
SeeBlue pre-stained standard marker (Invitrogen, Carlsbad, CA) consisted of
nine pre-stained protein bands in the range of 6–188 kDa. The anti-mucin
antibody was generated in rabbits by immunization with purified Fc fusion
protein NFM containing the mucin plus the fifth FnIII domain in NF (Koticha et
al., 2005) and the anti-NF 186 generated against a synthetic peptide from mouse
(anti-NF pep) was purchased from Chemicon Inter. Inc. (www.chemicon.com).
Construction of NF variants
The QuikChange XLII Site-Directed Mutagenesis Kit (Stratagene, La Jolla,
CA) was used for generating mutant proteins using the PfuUltra enyzme
(Stratagene, La Jolla, CA). To generate NF with only the mucin domain,
NF186–Fn5 Fc was created through site-directed mutagenesis of pCR-NF186
Fc (Koticha et al., 2005) expressing the extracellular domain of rat NF186 fused
to human Fc, using the primers 5′-Cccgacgagcagtccatttggtacaccaacaaccagact-
gac-3′ and 5′-gtcagtctggttgttggtgtaccaaatggactgctcgtcggg-3′, with the midpoint
of these partially overlapping primers containing a deletion of the fifth FnIII
repeat of NF186 (nucleotides 4406–4654). Restriction digestion with SmaI and
sequencing confirmed that this construct represented the extracellular regions of
NF186 without the fifth FnIII domain.
To evaluate possible functions of the exon 17 in NF186, the NF186–Fn5–
X17 construct was created through site-directed mutagenesis of NF186–Fn5 Fc
using primers 5′-gcctacctcactgttctagggcggccagaccgaccc-3′ and 5′-gggtcggtctg-
gccgccctagaacagtgaggtaggc-3′ to introduce a deletion of exon 17, at the alter-
native splice site between the sixth Ig domain and the first FnIII domain of
NF186 (nucleotides 2870–2914). This deletion was confirmed by PCR analysis
with primers flanking exon 17, in addition to sequencing.
A NF variant lacking the mucin domain (mc) but with the fifth FnIII domain,
NF186–mucin (NF186–mc Fc), was created through site-directed mutagenesis
of pCR-NF186 Fc (Koticha et al., 2005) using primers 5′-Tactccaactgcagc-
taacgtcacggtgctc-3′ and 5′-gagcaccgtgacgttagctgcagttggagta-3′, with the mid-
point of these primers deleting the mucin domain (nucleotides 4148–4405). This
construct was confirmed with ScaI restriction digestion and sequencing. A
construct calledNF186–M, lacking bothmucin and fifth FnIII, was produced as a
fusion protein (Koticha et al., 2005). Proteins expressed by each construct were
validated by Western blot.
Transfection, protein production, purification and analysis
Procedures were performed as described (Koticha et al., 2005). Briefly, HEK
293 cells were transfected with plasmids encoding the recombinant NF FcFig. 1. Expression of neuronal NF isoforms in DRG during development of the
PNS. (A) Schematic representation of the regions in NF186 where primers
specific to various exons and domains were designed to amplify unique regions
in the gene. Another set of primers that flanks the fourth FnIII domain to the
cytoplasmic domain was used to detect isoforms containing the mucin and/or
fifth FnIII domains. Various sized amplicons are depicted by solid lines and open
boxes and indicate potential alternative splicing variants. (B) Q-PCR of regions
of NF186 shows upregulation of all NF186-specific regions from E15 to E18,
followed by a precipitous drop in mRNA expression of these postnatally;
relative intensities were normalized to the average for E15 samples in each case.
Insert shows PCR of SCIP and S100β in embryonic DRG and postnatal sciatic
nerve samples. AU, arbitrary units; SN, sciatic nerve. (C) PCR products of
specific isoforms with or without mucin and/or fifth FnIII from E13 to E18
DRGs, with NF186-GFP as a control. Note the shift from the 562-bp product to
the predominant neuronal (NF186) product at E18 (1142 bp). E15 DRG also
showed additional bands corresponding to NF186 lacking the fifth FnIII repeat
(840 bp), and NF186 lacking the mucin domain (862 bp). At E18, the major
neuronal form corresponded to NF186 with very low levels of other forms. (D)
Summary of relative levels of the isoforms visualized at each age in DRG. ND,
not detectable. (E) Expression of NF proteins in DRGs at E15 and E18 as
detected by Western blot analysis. Note the increase in intensities of high
molecular weight bands from E15 to E18 with both anti-mucin and anti-NF pep
antibodies. Bands corresponding to tubulin confirm equal amounts of proteins in
each lane.
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fectants were isolated and Fc fusion proteins were bound to Ultralink Protein-A
beads (Pierce, Rockford, IL) and eluted using Pierce Gentle Ag/Ab Elution
Buffer (Pierce, Rockford, IL) (Haspel et al., 2000). Proteins were dialyzed
against Tris-buffered saline solution (pH 7.5) and concentrations were estimated
by Bradford assay (Biorad Kit, Hercules, CA). Purity of the proteins was deter-
mined by electrophoresis on 7.5% SDS–PAGE gels and confirmed by Western
blot using HRP–anti-human Fc antibody (Jackson ImmunoResearch, West
Grove, PA).
Fluorescent bead aggregation was performed as described (Jacob et al., 2002)
using 1 μm diameter yellow/green and Blue protein-A beads (Polysciences,
Warrington, VA). Nine μl of bead slurry were mixed in 200 μl with 15 μg of each
protein. For homophilic bead binding, green beads were used to bind Fc fusion
proteins including NF186–Fn5, NF186–Fn5–X17, NF186–mc, NF186,
NF186–M, NF155 and L1-1212 in PBS at pH 8.0. SDS–PAGE analysis
confirmed that equal amounts of each protein were bound to the beads (see Fig.
3B). The beads were sonicated for 20 s and the time course of reaggregation of
beads was measured semiquantitatively by microscopy and then aggregation was
quantified using a Coulter Counter set to count superthreshold particles between
2.5 and 6 μm as described (Grumet and Edelman, 1988).
Schwann cell adhesion and Fc binding assays were performed as described
(Koticha et al., 2005). For image analysis and quantification, 6 images were
averaged for each sample. To quantify Fc binding to cells, intensity thresholds
were set to remove non-specific fluorescence of the substrate and regions cor-
responding to Schwann cells were selected on the monolayers by S100β
immunostaining (Sigma, MO). Binding was calculated as the ratio of the protein
binding area of the cell/total S100+ area.
NF knockdown in Schwann Cell-DRG neuron co-cultures
The pSIREN kit BD™Knockout Clone and Confirm Adeno RNAi System 2
fromClontech (CA,USA)was used to generate siRNA against different isoforms
of NF. Primers targeting the second FnIII repeat of NF were designed using the
software tool on the Clontech website (http://bioinfo2.clontech.com/
rnaidesigner/). Three sets of primers were synthesized and ligated into the pre-
cut pSIREN-DNR-Express vector according to the manufacturer's protocol.
These siRNAs were functionally tested by co-transfection of these siRNA
expressing constructs together with pNF-186-EGFP into HEK 293 cells. Of the
three sequences the primers, 5′gatccAAACCCGAGAGACTTGGAACATT-
CAAGAGATGTTCCAAGTCTCTCGGGTTTTTTTTTACGCGTg and 5′aatt-
cACGCGTAAAAAAAAACCCGAGAGACTTGGAACATCTCTT-
GAATGTTCCAAGTCTCTCGGGTTTg were the best at reducing protein
expression. The adenoviral expression vectors were generated commercially
(Vector Biolabs, Philadelphia, PA). Briefly, pSIREN plasmids were subcloned
into premade shuttle vectors expressing GFP under the control of a CMV
promoter and were recombined into an adenoviral genome vector. The
recombinant adenoviral plasmid was transfected into HEK 293 cells for virus
amplification and production. The virus was then tested for knockdown of
specific NF genes in Schwann cells and on myelination in DRG–Schwann cell
co-culture system. A non-specific scrambled RNAi adenovirus expressing GFP
alone was purchased from Vector Biolabs and used as a control.
Near confluent Schwann cell cultures were infected with various Adeno
siRNAGFP viruses at titers that resulted in 90–100% cellular expression of GFP
within 48 h. E16 dissociated DRG neuron-enriched cultures were seeded with
200,000 Adeno NF siRNA-GFP Schwann cells or Adeno Scrambled siRNA
GFP Schwann cells or uninfected control Schwann cells. The media was then
changed to C-media with 50 ng/ml vitamin C (C+C) and grown in myelination
medium and immunostained as described (Ching et al., 1999; Lustig et al.,
2001).
For staining, primary antibodies included chicken anti-P0 IgY (Aves Labs.
Inc, OR) for staining myelin, monoclonal anti-Pan NF (gift from Dr. Matt
Rasband) for labeling node/paranode and polyclonal anti-Caspr 6061(Gift from
Dr. Elior Peles) for labeling paranode. Secondary antibodies (Jackson
ImmunoResearch, West Grove, PA) included AMCA-conjugated donkey anti-
chicken IgY, Alexa 568-conjugated goat anti-mouse IgG and Cy5-conjugated
goat anti-rabbit IgG. Cultures were fixed with 4% paraformaldehyde in
Dulbecco's PBS (dPBS) for 10 min, permeabilized with methanol at −20 °C
(20 min), and blocked for 2 h in dPBS/1% BSA/1% normal donkey serum/0.2%Triton X-100. Primary antibodies were added overnight at 4 °C and secondary
antibodies were used for 2 h at room temperature. Cultures were washed several
times with dPBS, once with distilled water, and mounted in Gel mount
(Biomedia).
Image analysis and quantification using LSM510
Images were acquired using the LSM 510 confocal microscope and analyzed
using LSM software (Zeiss, Thornwood, NY). In DRG neuron–Schwann cell
co-culture experiments, positive staining was scored manually for node/
paranode proteins when detected in a pattern resembling controls (see Fig. 8B).
NF clusters were scored as a full nodes when bounded by Caspr on both sides
adjacent to P0+ segments, and as heminodes when adjacent to a single Caspr
cluster bordering a P0+ segment (Koticha et al., 2006); other combinations of
NF clusters were scored as incomplete (see Fig. 8B). Heminodes were scored as
normal when both NF and Caspr were robust, but when robust clustering of only
one of these two markers was located adjacent to a P0+ segment it was scored as
incomplete. For quantification of myelination in co-cultures stained for P0, four
tile-scan images consisting of nine 25× images (Koticha et al., 2006) were
analyzed with LSM 510/Multi Time macro (Carl Zeiss, Thornwood, NY). Total
imaged area was approximately 4.2 mm2 of DRG–Schwann cell co-culture,
which covered approximately 5% of the entire coverslip. Due to the depth of the
myelinated co-culture (approximately 15–22 μm), Z-stacks were imaged at
0.85 μm intervals. The 3-D maximum intensity projection was created from the
tile-scan Z-stack images and analyzed for myelinated area by thresholding for
P0-positive areas (Koticha et al., 2006) and statistical analysis (ANOVA/post
hoc) was performed.
Results
Transient upregulation of NF in neurons before myelination
Mammalian neurons express NF186 that includes exons 3
and 17 but not exon 8. Conversely, oligodendroglia express
NF155 that includes exon 8 but not exons 3 and 17. Thus
neuronal and glial NF isoforms may be distinguished by pat-
terns of exon splicing (Davis et al., 1996; Hassel et al., 1997).
To analyze the differential expression of neuronal NF mRNAs
in PNS development, RT–PCR was used to amplify from
DRGs, which are enriched in neuronal cell bodies, regions
unique to the neuronal isoform (Fig. 1A). PCR of RNA in
embryonic DRGs detected SCIP indicating the presence of
Schwann cell precursors (Blanchard et al., 1996; Zorick and
Lemke, 1996) that were not detected in postnatal sciatic nerve,
and conversely the Schwann cell marker S100β (Aquino et al.,
2006; Jessen and Mirsky, 1991) was found in the nerve but not
in E13–15 DRGs (Fig. 1B, insert). These results confirm the
presence of Schwann cell precursors in embryonic DRGs and
Schwann cells in the sciatic nerve but not in E13–E15 DRGs.
To quantitate the developmental changes of regions unique
to neuronal NF, we measured the relative expression levels of
various products by Q-PCR (Fig. 1B). The relative intensities of
each amplicon were normalized by defining the intensity at E15
as 1. The relative changes during development in each exon or
region tested was greater than that observed for total NF (cyto)
suggesting complex changes in various NF isoforms. The
expression of mucin and the fifth FnIII increased from E15 to
E18 in DRG, but they decreased dramatically by P1 (about 10-
fold) and remained relatively low through P4 (Fig. 1B). Ex-
pression of exons 3 and 17 also showed transient upregulation
peaking around E18 (Fig. 1B). The dramatic postnatal decrease
Fig. 2. NF155 mRNA expression correlates temporally with myelination by
Schwann cells in PNS. (A) Schematic representation of the regions in NF155
where primers were designed to amplify regions of the gene. (B) Q-PCR of the
cytoplasmic domain of NF (indicative of total NF expression), the third FnIII
repeat in NF155, and the mucin domain of NF186 as an indicator of neuronal
NF, were expressed relative to their maximal intensities at P8 for cyto and FN3
and at E18 for mucin (see Fig. 1B). Upregulation of the third FnIII repeat
paralleled that of total NF from P2 through P8 in sciatic nerve. Relative
intensities of NF186 expression (as measured by mucin expression) in P0 to P8
sciatic nerve were only 1–2% of its maximum in E18 DRG (Fig. 1). (C) Q-PCR
comparison of NF155 expression (the third FnIII repeat) with MBP and
gliomedin showed that early upregulation of NF155 mRNA expression between
P0 and P3 coincided closely with upregulation of MBP and gliomedin
transcripts. AU, arbitrary units.
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correlated with the decrease in total NF expression in DRG as
measured by the conserved cytoplasmic (cyto) region in NF
(Fig. 1B). Prenatally, total NF in DRGs is likely to represent
neuronal NF since Schwann cell NF was only detected after
birth (see Fig. 2). These results indicate that exons associated
with neuronal isoforms of NF mRNAs are transiently upregu-
lated in DRG before birth and they drop precipitously after
birth.
To analyze which isoforms of NF are expressed at different
ages during development, longer-range PCR was performed
with primers flanking the mucin and the fifth FnIII domain (Fig.
1A). PCR with primers spanning the NF186 isoform from the
end of the fourth FnIII repeat to the cytoplasmic domain, re-
vealed a series of products including the mature form repre-
senting NF186 (Tait et al., 2000) which was predominant in E18
DRG (Fig. 1C). The mature form containing both the mucin and
fifth FnIII domains is predicted to yield a PCR product of
1142 bp. At E13, NF expression was relatively weak and the
predominant isoform was represented by a PCR product
predicted to be 562 bp, lacking both the mucin and fifth FnIII
domains of NF (Figs. 1C and D). At least two additional
isoforms were detected at E15 corresponding to products of
isoforms containing either the mucin (840 bp) or the fifth FnIII
(862 bp) domain but not both. The combined results (summa-
rized in Fig. 1D) suggest that NF is first expressed as an isoform
lacking both the fifth FnIII domain and the mucin domain, and
by E15 at least three other mRNA isoforms are expressed that
include the fifth FnIII domain or the mucin domain or both
domains. The form containing both domains is dominant by
E18 in DRG and corresponds to the mature neuronal form
described previously (Davis et al., 1996; Tait et al., 2000).
To evaluate whether these splice variants are translated into
mature proteins during development we performed Western blot
analysis of lysates of DRGs derived from E15 and E18 embryos
(Fig. 1E). At both ages, bands at ∼186 kDa were detected by a
polyclonal antibody generated against the mucin domain in NF
and the intensity of the protein at E18 was higher than that at
E15 (Fig. 1E). Another antibody specific for NF186 (anti-NF
pep) also recognized high molecular weight bands that were
more prevalent at E18 than E15 (Fig. 1E). Equal reactivity using
anti-tubulin confirmed equal amounts of proteins in each lane.
The results suggest that the high molecular weight bands repre-
sent major neuronal NF186 forms containing the mucin domain,
which are upregulated during late embryogenesis. Although
additional NF isoforms were detected by RT–PCR analysis
during early stages of development, we have not been able to
identify proteins that correspond to them.
NF155 mRNA expression parallels myelination by glia in the
PNS
A previous study in the rat CNS showed that NF is strongly
but transiently up-regulated in oligodendrocytes at the onset of
myelinogenesis followed by a shift to a predominantly neuronal
localization that persisted into adulthood (Collinson et al.,
1998). To investigate whether NF isoforms are differentially
413S. Basak et al. / Developmental Biology 311 (2007) 408–422expressed in PNS glia as well, we analyzed the timing and the
expression profiles of different NF isoforms in developing rat
sciatic nerve that is rich in Schwann cells but not neuronal cell
bodies. Q-PCR analysis using a primer set to target the FN3
domains specific to NF155 indicated that NF155 mRNA ex-
pression was dramatically upregulated from P2 through P8 in
sciatic nerve (Fig. 2). Similarly, PCR products representing total
NF rose dramatically from P2 through P8 in sciatic nerve (Fig.
2B). In contrast, the major neuronal NF form including the
mucin domain was detected in embryonic DRGs (Fig. 1), but
not in early postnatal sciatic nerve (Fig. 2B). These results
suggest that NF155 expression coincides with the onset of
myelination in the PNS early postnatally. The very low levels of
total NF expression in P0 and P1 sciatic nerve suggests that
Schwann cell precursors express little or no NF and it is upre-
gulated as they mature into Schwann cells. We confirmed that
the early upregulation of NF155 mRNA between P0 and P3
correlated closely with the expression of mRNAs for MBP and
gliomedin (Fig. 2C), proteins that are associated with early
stages of myelination and node formation (Eshed et al., 2005).
The combined results indicate that only glial NF mRNAs iso-
forms are found in postnatal sciatic nerve and suggest that
Schwann cells upregulate NF155 mRNA as they begin to mye-
linate axons.
Effects of NF exon splicing on binding
Given the diversity of neuronal NF isoforms and their
changing patterns of expression in the rat PNS during prenatal
development, we prepared Fc fusion proteins representing rat-
specific versions of the most prevalent variants to explore their
functions. Effects of NF splicing on binding and cell adhesion
were analyzed using deletion constructs. Considering data in
chick that NF22 lacks exon 17 (Hassel et al., 1997), we also
constructed a NF Fc lacking the fifth FnIII with (NF186–Fn5)
or without (NF186–Fn5–X17) exon 17. The purity of the Fc
fusion proteins was determined following electrophoresis on
SDS–PAGE gels (Fig. 3B) and, as expected, all the truncated
proteins had lower apparent molecular weights than NF186
(Fig. 3B) (Koticha et al., 2005).
We analyzed the binding properties of these NF Fc proteins
when bound to fluorescent Protein A beads. Beads coated with
NF186 Fc, NF155 Fc, and NF186–M Fc formed large aggre-
gates at 2 h of incubation with very few unaggregated beads (Fig.
3C). In contrast, NF proteins NF186–Fn5, NF186–Fn5–X17,
and NF186–mc exhibited smaller aggregates and more unaggre-Fig. 3. Homophilic binding of various NF isoforms. (A) Schematics show
different extracellular regions of NF (black) as Fc (grey) fusion proteins. (B)
SDS–PAGE gels of NF Fc proteins after purification. All three isoforms
(Koticha et al., 2005) are smaller than NF186, as expected. (C) Homophilic
reaggregation of Fc-bound Protein A beads showed stronger homophilic binding
for NF155, NF186, and NF186-M than other forms. L1-1212 was used as a
negative control and showed no homophilic reaggregation. (D) All proteins
showed relatively equivalent protein binding to beads. (E) Quantitative analysis
of homophilic binding of the NF Fc proteins (C), with a Coulter counter as
measured by counting of superthreshold aggregates between 2.5 and 6.0 μm in
size; results are from three experiments. Scale bar=20 μm (***Pb0.001).
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binding. SDS–PAGE analysis confirmed that all the proteins
bound equally well to Fluorosbrite Protein A-coated beads (Fig.
3D) indicating that differences in aggregation were not due to
variations in the amounts of bound Fc fusion proteins. All the NF
proteins, however, exhibited significantly greater levels of ag-
gregation than the negative control (L1-1212 Fc; Fig. 3D), which
had no detectable L1 binding activity (Haspel et al., 2000).
Quantification of numbers of superthreshold aggregates
supported visual analysis (Fig. 3E). The results indicate that the
earliest expressed form of NF in neurons (NF186–M) as well as
the mature forms (NF186, NF155) show stronger homophilic
binding than the transiently expressed forms (NF186–Fn5,
NF186–Fn5–X17 and NF186–mc) (Fig. 3E). Interestingly,
NF186–Fn5, which clearly showed some aggregation by com-
parison to the negative control L1-1212 Fc did not aggregate as
well as the same protein without exon 17 (NF186–Fn5–X17;
Fig. 3E), suggesting that this exon located at the hinge between
the Ig domains and the FnIII repeats in Ig/FnIII CAMs may
modulate homophilic binding in NF perhaps by regulating the
folding of the molecule (Haspel and Grumet, 2003). However,
we detected only weak levels of exon 17 expression at E15
DRG in the rat (Fig. 1B), thus, its function remains unclear.
Insofar as both early and later expressed NF isoforms exhibited
robust homophilic binding, the developmental changes in neu-
ronal NFs does not predict dramatic changes in NF homophilic
binding during this period of development.
We then analyzed binding of these NF variants to live cells as
described previously (Koticha et al., 2005). NF155 and NF186–
M Fc bound strongly to Schwann cells while NF186 exhibited
relatively little binding (Fig. 4) (Koticha et al., 2005). Both
NF186–Fn5 and NF186–Fn5–X17 (Fig. 4) exhibited weak
binding to Schwann cells that was similar to the level observed
for NF186 (Figs. 4B, E and F). However, binding of NF186–mc
lacking the mucin domain was strong and comparable to the
best NFs (Figs. 4G and H). Quantification of NF-Fc binding and
normalization to areas of the dish covered by Schwann cells
confirmed that NFs without mucin bind more robustly to
Schwann cell than NFs with mucin and that the mucin domain
itself had no detectable binding (Fig. 4H). The results confirm
that multiple NF variants bind to Schwann cells and suggest that
the presence of the mucin domain reduces the binding affinity or
avidity of neuronal NFs for glia. The results suggest that deve-
lopmental upregulation of NF186 may modulate Schwann cell
interactions with axons.
Maximal inhibition of adhesion by the mucin domain requires
the fifth FnIII repeat
Our previous studies (Koticha et al., 2005) showed that
NF186 inhibits Schwann cell adhesion and the inhibition in-
volves the M-region consisting of the mucin domain and the
fifth FnIII repeat. To localize this inhibitory activity further, we
tested adhesion of Schwann cells to the various recombinant NF
mutant proteins (Fig. 5A) (Koticha et al., 2005). Cells adhered
(Figs. 5B, C, G) and spread (Figs. 5J, K, O) within 2 h most
extensively on NF155, NF186–M and NF186–mc. Adhesionwas inhibited on NF186 (Figs. 5A, I) and NFM (Figs. 5D, L)
with reduced numbers of cells bound within the protein coated
spots (circles) and cells spread poorly on substrates coated with
NF186–Fn5 (Figs. 5E, M) or NF186–Fn5–X17 (Figs. 5F, N).
Quantitation of the adherent cells per field of view confirmed
that significantly greater numbers of cells adhered to NF186–
mc substrate (comparable to NF155, NF186–M, or L1) than to
NF186–Fn5 and NF186–Fn5–X17 substrates (Fig. 5Q). Very
few cells bound to NFM or to NF186 (Fig. 5Q). The combined
results indicate that the mucin along with fifth FnIII domain of
NF is required for maximal inhibition of glial adhesion and that
the mucin domain plays a critical role in this process. In add-
ition, the presence of the fifth FnIII repeat reduces cell spread-
ing even in the absence of the mucin domain but exon 17 did not
have a detectable affect. The developmental upregulation of
neuronal NF186 with its ability to inhibit cell adhesion suggests
that it may modulate interactions among axons as well as with
Schwann cells.
Knockdown of NF155 in Schwann cell delays myelination
slightly and inhibits Caspr clustering when co-cultured with
DRG neurons
Knockout of all NF isoforms in mice indicated that NFs are
necessary for clustering of specific proteins at nodes and para-
nodes, and rescue of NF155 in glia in knockout mice restored
formation of paranodal junctions but it did not rescue nodal
clustering (Sherman et al., 2005). Given one major form of NF
in glia, we decided to analyze its function specifically in these
cells by depletion using specific siRNAs introduced into
Schwann cells. Four siRNA sequences targeted to various re-
gions of NF were screened and the most effective one was
within the conserved second FnIII repeat (Supplementary Fig.
1). Adenoviral vectors encoding for expression of GFP as a
marker were prepared with this siRNA sequence and a
scrambled sequence as a control, and were used to infect
Schwann cells.
Six days after adding Schwann cells to DRG neurons, there
were few weakly P0+ myelin segments in both the siRNA
control and uninfected control co-cultures but none were ob-
served in co-cultures with the NF siRNA-treated Schwann cells
(Fig. 6A). These isolated myelin segments were bordered by
variably sized clusters of NF but Caspr remained diffusely
localized along axons at these early times. NF colocalized with
myelin segments only in controls but not in the NF siRNA-
treated Schwann cell co-cultures, suggesting that this NF is on
the Schwann cells (Fig. 6A). These results suggest that NF
RNAi inhibits induction of NF155 in Schwann cells despite
their close association with axons.
Both control and NF siRNA-infected GFP+ Schwann cells
elongated and associated closely with the axons although asso-
ciation of NF deficient Schwann cells was less distinct. Thus,
initial recognition between Schwann cells and axons does not
appear to be dependent on NF. Higher-magnification imaging
confirmed NF clustering adjacent to myelin segments en-
sheathed by GFP+ Schwann cells when the scrambled RNAi-
treated Schwann cells or control uninfected Schwann cells were
Fig. 4. Binding of NF isoforms to Schwann cell surface. (A–G) Binding of various NF Fc proteins to the surface of Schwann cells was detected after fixation and
immunofluorescence with S100β, which is shown as inserts in the upper right of each panel. (H) Quantification of protein-binding normalized to total S100β+ cell
areas confirmed the qualitative results and the absence of binding for NFM. NF155, NF186-M, and NF186-mc exhibited higher levels of protein binding to the surface
of Schwann cells relative to the other proteins. NF186, NF186-FN5, and NF186-FN5-X17 exhibited similar levels of protein binding to cell surfaces that was weaker,
while NFM shows almost no binding. Scale bar=10 μm. AU, arbitrary units.
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(Fig. 6B). These NF clusters are likely to represent neuronal NF
rather than glial NF since they were not accompanied by
clustering of Caspr. This is consistent with the observations that
neuronal NF can cluster without Caspr but glial NF colocalized
with Caspr (Schafer et al., 2006). In all three conditions, Caspr
served as a marker for axons at this early time since it remained
diffusely distributed along axons.
Confocal microscopy revealed close association of GFP+
Schwann cells with axons but this was particularly difficult to
visualize since GFP was in the cytoplasm and was most pre-
valent around cell bodies but sparse in the extended processes.
Given that myelin contains very little cytoplasm, the GFP
signals are likely to be more faint in regions of Schwann cells
where they ensheath and myelinate axons. Nevertheless, we
have detected weak GFP+ tubular profiles overlapping P0+regions in myelination co-cultures at 6 and 12 days (Fig. 6B and
see Fig. 8B). In the older 19-day cultures, it was extremely
difficult to visualize GFP in myelinated processes and we
therefore focused on the younger cultures.
After incubation for 12 days, there was extensive myelina-
tion in all groups including the NF siRNA-infected Schwann
cells co-cultured with DRG neurons (Fig. 7A). Although
slightly less myelinated areas was measured in 12 days
knockdown cultures, the percentage of myelinated areas were
not statistically different among control uninfected Schwann
cells, control siRNA-infected Schwann cells, and the NF
siRNA-infected Schwann cells at 12 days or 19 days (Figs. 7A
and B). Quantitation was not done on the 6-day cultures because
P0 signals were weak and variable, and no myelin was detected
with the NF siRNA-treated Schwann cells (Fig. 6). The
combined results suggest that knockdown of NF results in a
Fig. 5. Inhibition of adhesion and spreading of NF186 by the mucin domain requires the fifth FnIII repeat. The adhesion and spreading of Schwann cells on NF Fc
protein coated substrates within circular areas was analyzed. Circles represent areas where the proteins were spotted. (A–H) NF155, NF186-M, and L1 permitted
adhesion of Schwann cells, as did NF186-mc. NF186-Fn5 and NF186-Fn5-X17 both permitted reduced levels of Schwann cell adhesion that were higher than levels
seen with NF186 and NFM that showed little to no Schwann cell adhesion, 2.5× phase magnification. (I–P) At 10× magnification, Schwann cells spread well on
NF155, NF186-M, NF186-mc and L1 substrates, less on NF186-Fn5 and NF186-Fn5-X17, and negligibly on NF186 or NFM. (Q) Quantification of the number of
adherent cells for each protein per field of view. Scale bar=100 μm in panels A–H; 400 μm in panels I–P (***Pb0.001).
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myelination when the culture is allowed to develop for longer
times.
To analyze the effect of NF knockdown in Schwann cells on
clustering of nodal and paranodal proteins, co-cultures were
stained for P0, NF and Caspr. At 12 and 19 days when there was
extensive myelination indicated by strong P0 staining (Fig. 7),
both control and scrambled RNAi treated Schwann cell–DRG
neuron co-cultures exhibited well delineated paranodes and
nodes containing clusters of Caspr and NF, respectively,
adjacent to ends of P0+ segments (Fig. 8A). Based on previous
studies, we defined normal paranodes by Capsr clustering
(Salzer, 2003). Mature (full) nodes exhibited staining with a Pan
NF antibody in both nodal (neuronal) and paranodal (glial)
regions while Caspr appeared as a doublet separated by NFstaining (Fig. 8B) (Schafer et al., 2006). Heminodes are defined
by NF clusters with more focal Caspr at one end and incomplete
clusters with little or no Caspr clustering were frequently found
with the NF siRNA-infected Schwann cells (Figs. 8A, B). In the
12-day cultures, there appeared to be fewer full nodes with the
NF siRNA-infected Schwann cells than the cultures with the
control Schwann cells. To analyze this quantitatively, we
counted the numbers of full nodes and NF clusters and then
calculated the percent of the total that were full nodes (Fig. 8B).
At 12 days, only 7.7% of clusters were scored as full nodes with
the NF siRNA-treated Schwann cells while 35.6% were found
in the scrambled siRNA control and 48.7% in the uninfected
Schwann cell control. One week later at 19 days, there was still
a trend showing fewer full nodes in the NF siRNA-treated
Schwann cells but the differences were no longer significant as
Fig. 6. NF siRNA in Schwann cells inhibits Caspr clustering and initial myelination in cocultures in vitro. (A) Schwann cells without or with infection with NF siRNA
(A-NF RNAi) or scrambled siRNA control (A-scrambled RNAi) were co-cultured with DRG neurons and immunostained for NF (red), Caspr (purple) and P0 (blue) as
described in materials and methods. After 6 days, several weakly P0+ segments could be seen in co-cultures of DRG neurons with either uninfected control Schwann
cells or scrambled siRNA-infected GFP Schwann cells but not in the NF siRNA-treated GFP+ Schwann cell–DRG neuron co-cultures. Variable sized clusters of NF
were seen at heminodes (arrows) in control and scrambled siRNA groups but not in the NF siRNA-treated group. Capsr was diffusely distributed on axons including
those covered with P0+ segments but it was not yet found to be clustered at this early time point. (B) Higher-magnification images confirm the presence of NF clusters
adjacent to P0+ myelinated segments in control and scrambled siRNA-infected GFP Schwann cell groups but not in the NF siRNA group. Parallel white lines mark
GFP+ Schwann cells associated with P0+ segments overlying Caspr+axons. In contrast to control Schwann cells, in the knockdown Schwann cells there was poor
correlation of P0 staining along Caspr+axons with overlying GFP Schwann cells.
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Fig. 7. Knockdown of NF in Schwann cells did not inhibit the extent of myelination significantly in co-culture. (A) Images of P0 staining (nine non-adjacent
predetermined locations at 25×) of day 12 and day 19 cultures were taken covering approximately 4.2 mm2 per coverslip. The P0+ DRG somas were masked using
LSM510-histogram software and the P0+ myelinated fibers were detected after thresholding to remove background. The percentage of P0+ pixels over the entire
imaged area was measured (B). Although NF siRNA had slightly lower myelinated areas compared to control and scrambled siRNA at the 12-day time point, no
significant differences were found by ANOVA/post hoc analysis. Scale bar=10 μm.
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were fewer mature full nodes in co-cultures with NF siRNA-
treated Schwann cells. The observation that this affect was no
longer significant 1 week later suggests that the knockdown of
glial NF only delays development of node formation because
the knockdown may not be not complete and eventually glial
NF is expressed and clustered at the paranode.
To analyze further the effects on NF knockdown in Schwann
cells, we focused primarily on formation of immature clusters in
12-day cultures. Heminode formation was analyzed in higher
magnification images of DRG neuron co-cultures at 12 days
(Figs. 8C and D) and 19 days (E). Since the Pan NF antibody
recognizes both glial and neuronal NF, we compared its
localization with Caspr, which clusters at paranodes (demar-
cated by 4 white dots), to distinguish putative overlapping
paranodal and non-overlapping nodal regions adjacent to P0+
myelin segments as described (Schafer et al., 2006). In cultures
with uninfected or control infected Schwann cells, the part of
the NF staining region adjacent to the P0+ myelin segment
typically overlapped with a Caspr cluster (white arrowhead).
Weak GFP+ tubular profiles of control infected Schwann cells
were observed associated with the P0+ segments bounded by
Caspr clusters and overlapping axons that were weakly Caspr+
(Fig. 8C right panels, white arrow). In both control Schwann
cell cultures, a region of NF clustering (red arrow) was detected
that did not overlap with Caspr clustering and is likely to
represent nodal neuronal NF while in the control the over-
lapping region with Caspr is likely to be glial NF (Schafer et al.,
2006). In cultures with NF siRNA-treated Schwann cells,
narrow clusters of NF (red arrow) were frequently observed at
ends of P0+ segments without Caspr clustering on the axon
(Fig. 8C middle panel, white arrow) that probably representneuronal NF in the absence of NF on the associated Schwann
cell.
To analyze the effects of viral infection and siRNA in these
cultures, we counted the numbers of normal appearing
heminodes with an overlapping region of Caspr cluster adjacent
to a P0+ myelin segment and incomplete clusters that showed
clear clustering of either NF (e.g. Fig. 8B) or Caspr but not both.
In co-cultures with uninfected Schwann cells, 83% of NF
clusters appeared as normal heminodes in 12-day cultures (Figs.
8C and D). The fraction of normal appearing heminodes was
somewhat lower (67%) in the co-cultures with scrambled
siRNA control Schwann cells but it was significantly lower
(15%) in co-cultures with the NF siRNA-treated Schwann cells
(Figs. 8C and D). Conversely the proportion of incomplete
heminodes, in particular, those with clusters of NF without
Caspr (Fig. 8C middle panels) was relatively high in the NF
knockdown cultures (22%) but very rare (2%) or not detected
with the control infected or uninfected Schwann cells co-
cultures, respectively. Thus, nodal clustering of neuronal NF
can proceed without Caspr clustering in culture. Most of the
clusters in the cultures with the knockdown Schwann cells
showed incomplete combinations of NF and Caspr staining. The
incomplete clusters were present in somewhat higher propor-
tions in the infected controls than the non-infected Schwann cell
cultures, suggesting there may be a mild effect of the virus on
the Schwann cells. However, in the 19-day cultures, the
differences between the NF siRNA and the scrambled siRNA
control were no longer significant, again suggesting that the NF
knockdown is incomplete and the effects of the virus on the
maturation of the cultures are modest by comparison to the
siRNA effect. The combined results on the timing of
myelination and clustering of proteins support the idea that
Fig. 8. NF155 siRNA in Schwann cells inhibits Caspr and NF clustering at presumptive paranodes adjacent to myelin segments in vitro. Schwann cells either
uninfected (control) or infected with Adeno NF siRNA GFP (A-NF RNAi) or Adeno scrambled siRNA GFP (A-Scrambled RNAi) were co-cultured with DRG
neurons, fixed at days 12 and 19 and then stained for NF (red), Caspr (purple) and P0 (blue) as described in legend to Fig. 6. (A) Confocal images show several fully
developed nodes in the uninfected control and the A-scrambled RNAi-treated control, but they were rarely found in co-cultures with A-NF RNAi Schwann cells
deficient for NF in the 12-day cultures. (B) For quantitation, we scored NF cluster as full (bounded by Caspr on both sides), as heminodes with Caspr only on one side
of a NF clusters or incomplete, without clear Caspr association. The percentage of the number of cluster that were full nodes were calculated and shown; the total
numbers of clusters scored were 75 and 138 for controls, 52 and 123 for A-NF RNAi, and 85 and 110 for A-Scrambled RNAi at 12 and 19 days, respectively.
Significantly fewer full nodes were found in the NF RNAi-treated co-cultures by comparison to controls in day 12 co-cultures, but differences at day 19 were not
significant. Heminode formation was analyzed in higher magnification images of DRG neuron co-cultures at 12 days (C and D) and 19 days (E) with three types of
Schwann cells; the total numbers of clusters scored were 71 and 123 for controls, 68 and 124 for A-NF RNAi, and 84 and 89 for A-Scrambled RNAi at 12 and 19 days,
respectively. (C) Columns show staining of the same field of control. Caspr clusters were surrounded by 4 white dots to distinguish putative overlapping paranodal
(white arrowheads) and non-overlapping nodal regions (red arrows) adjacent to P0+ myelin segments (white arrows); white arrows also mark axons with weak Caspr
staining. Weak GFP+ tubular profiles were observed associated with these P0+ segments that were bounded by Caspr clusters only with control Schwann cells and
overlapping weakly Caspr+axons (C, right panels, white arrow). Note the lack of Caspr clustering on Caspr+axons that have NF clusters adjacent to P0+ myelin
segments of GFP+ Schwann cells infected with the A-NF RNAi (middle panels) and these were scored as incomplete heminodes (B). Regions of presumptive neuronal
NF clustering (red arrow) were detected that did not overlap with Caspr clustering in both control and treated cultures. (D, E) The percent of normal heminodes was
calculated as the fraction of all clusters including incomplete heminodes. Data are averages of 2 (B) or 3 (D, E) independent experiments each consisting of 6–40×
fields per group (∗∗Pb0.01; ∗∗∗Pb0.001). Scale bar=10 μm in panel A; 5 μm in panel C.
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420 S. Basak et al. / Developmental Biology 311 (2007) 408–422knocking down NF expression selectively in Schwann cells
results in a slight delay in myelination and a significant delay in
paranodal formation however nodal NF clustering appeared to
proceed even in the absence of Caspr clustering.
Discussion
The results show dramatic differences in expression and
functions of several major NF isoforms that are expressed on
neurons and glia during PNS development. We found that
mammals express multiple alternatively spliced forms of NF as
predicted from a study in chicken (Hassel et al., 1997). Three
neuronal isoforms may be transiently upregulated in DRG be-
fore total neuronal NF mRNAs are dramatically down regulated
prior to birth. Glial NF is not expressed until after birth when it
is dramatically upregulated coincident with the onset of mye-
lination in the sciatic nerve. Thus, expression of neuronal and
glial NF mRNAs peak transiently before and after birth, res-
pectively, in a complementary pattern (Fig. 9). Our knockdown
studies of NF specifically in rat Schwann cells demonstrate that
it is critical for formation of paranodes confirming knockout
studies in mice that eliminated all NF isoforms (Sherman et al.,
2005). They further suggest that glial NF is not necessary for
clustering of receptors including neuronal NF at the node of
Ranvier. These studies combined with previous studies (Davis
et al., 1996; Lambert et al., 1997; Lustig et al., 2001; Sherman et
al., 2005; Tait et al., 2000) further underscore that neuronal and
glial NF isoforms play different roles in development of the
node of Ranvier and the paranode, respectively.
Changes in NF isoforms during development suggest dra-
matic differences in the potential functions of the various neu-
ronal isoforms expressed prior to myelination. Neuronal iso-
forms of NF were first detected at E13 in rat and they were
found to lack the mucin and fifth FnIII domains similar to the
NF166 isoform detected early in chick development (Hassel et
al., 1997). By E15, at least two more isoforms are detected,
one similar to chicken NF22 containing the fifth FnIII domainFig. 9. Model summarizing expression patterns of major NF isoforms during
development. The mature neuronal form (NF186, blue) is dramatically upre-
gulated as axons are ensheathed and then it decreases to persist at low levels
postnatally. In contrast, the glial form (NF155, green) is only expressed post-
natally at the onset of myelination.(Pruss et al., 2004) and the other contains the mucin but not the
fifth FnIII domain. Functional analyses indicate that all three of
these early embryonic forms bind homophilically (Fig. 3) and
NF also binds heterophilically with axonin-1, contactin and Nr-
CAM (Pruss et al., 2004; Volkmer et al., 1998), thus NF may
initially promote axonal fasciculation by multiple mechanisms
(Rathjen et al., 1987). The mature neuronal isoform containing
both the mucin and the fifth FnIII domains predominates by E18
in rat. This isoform of NF also binds homophilically but it is a
strong inhibitor of cell adhesion (Fig. 5), suggesting that it may
be involved in defasciculation of axons at later times (Koticha et
al., 2005). Regulated switching from NF166 to NF185 was
found in chick DRG, consistent with the observation that the
latter form containing the mucin and the fifth FnIII domains is
poorly adhesive for cells (Pruss et al., 2006). Changes in other
exons such as 17 were also observed but no evidence for their
modulation of NF function has been found yet. However, the
function of the immature neuronal NF isoforms is uncertain
since evidence for expression of the predicted proteins has yet to
be obtained.
Although neuronal NF mRNA drops to relatively low levels
postnatally, NF186 persists in mature nerves and is highly
restricted to the node of Ranvier. Neuronal NF may be critical
for co-clustering of sodium channels via cis interaction between
these proteins on axons (Ratcliffe et al., 2001). Recent studies
(Dzhashiashvili et al., 2007) indicate that it may be targeted
directly to the node which could explain how relatively low
levels of mRNA expression postnatally are sufficient to main-
tain its high expression specifically at the node. In NF null mice,
adjacent Schwann cells contacted each other in presumptive
nodal regions lacking NF186 (Sherman et al., 2005), consistent
with the proposal that the inhibition of cell adhesion by NF186
plays a critical role in limiting cellular contacts at nodes of
Ranvier (Koticha et al., 2005). Thus, the inhibition of cell
adhesion by NF186 may explain why Schwann cell processes
do not form stable contacts in the nodal region. However, glio-
medin on Schwann cells mediates binding to axons via NF and
NrCAM (Eshed et al., 2005), and may provide a mechanism for
axo-glial interactions that allows Schwann cells to associate
with axons despite the inhibition by NF186. Although NF does
not appear to be directly involved in myelination (Sherman et
al., 2005) (Koticha et al., 2006) (Fig. 7), glial NF plays a critical
role in paranodal formation (Sherman et al., 2005) (Fig. 8). In
the absence of glial NF, Caspr does not cluster, but neuronal NF
can still form clusters adjacent to incomplete paranodal junc-
tions (Fig. 8B) that border myelin sheaths (Sherman et al.,
2005). Thus, neuronal and glial NFs play different functions
that are likely to be related to their differential spatiotemporal
patterns of expression and perhaps their compositions due to
splicing.
The different forms of NF described here were clearly dis-
tinguishable based on their inclusion of specific exons that ex-
hibited complementary patterns of expression in cell bodies of
DRG neurons (Fig. 1) and Schwann cells in sciatic nerves (Fig.
2), consistent with previous studies that detected them in neu-
rons and glia (Collinson et al., 1998; Davis et al., 1996; Tait et
al., 2000). The Pan NF monoclonal antibody (Schafer et al.,
421S. Basak et al. / Developmental Biology 311 (2007) 408–4222004) was critical for detecting clusters of NF during myeli-
nation in co-cultures and showing that they were disrupted by
specific NF siRNAs in Schwann cells. Although study of native
NF proteins is extremely complicated by the large possible
number of isoforms expressed in different cells and their mul-
tiple post-translational modifications including glycosylation
and cleavage (Maier et al., 2006; Pruss et al., 2006; Volkmer et
al., 1992), the analysis of the mRNAs by Q-PCR revealed
dramatic changes in neurons and glia. We have detected NF
proteins that are upregulated between E15 and E18 in DRGs
corresponding to mature NF with mucin, suggesting that they
are predominant in DRG neurons before myelination.
Mammalian studies demonstrated localization of Nr-CAM
and NF at nascent nodes of Ranvier as early as P2 in sciatic
nerves, prior to clustering of sodium channels and ankyrinG
(Custer et al., 2003; Lambert et al., 1997). Although the Pan NF
monoclonal antibody (Schafer et al., 2004) does not distinguish
among NF isoforms, it may allow detection of NF at earlier
times than other anti-NF antibodies that are available (Schafer et
al., 2004). Comparison of NF with the paranodal protein Caspr
showed that early postnatally NF clusters partially overlap with
Caspr at heminodes and NF clusters were occasionally detected
without Caspr clustering (Schafer et al., 2006). We found that
knockdown of glial NF in Schwann cells increased the fre-
quency of finding NF clusters (presumably neuronal) without
adjacent Caspr clusters, confirming that NF on axons can cluster
independent of Caspr. In early phases of co-cultures, myelina-
tion was only detected with control Schwann cells, on which P0
colocalized with NF staining, suggesting this is glial NF that
was not expressed on knockdown Schwann cells. Thus NF is
not essential for myelination but neuronal NF plays a critical
role in nodal clustering (Sherman et al., 2005).
In conclusion, NF mRNAs that are expressed first on DRG
neurons during development including NF186–M, NF186–mc,
NF186–Fn5, encode proteins that can bind homophilically and
may contribute to initial axonal fasciculation along with other
CAMs (Chang et al., 1987). By comparison to other prevalent
neural CAMs such as L1 that mediate homophilic binding
(Haspel and Grumet, 2003), NF exhibits robust homophilic
binding on beads in vitro (Fig. 3). Subsequent upregulation of
NF186 may favor defasciculation of DRG axons due to its
inhibition of cell adhesion mediated by neural CAMs including
NF and L1 (Koticha et al., 2005). However, NF186 does not
inhibit laminin-mediated adhesion (Koticha et al., 2005),
consistent with the observed increase in extracellular matrix
and association of Schwann cells in the nerve by E18 (Wanner
et al., 2006). At least at early times in DRG–Schwann cell
cultures, we detected NF on neuron-associated Schwann cells
and Caspr distributed along axons before these proteins co-
cluster at paranodes along with contactin on the axon (Girault
and Peles, 2002). It is also appears by electron microscopy that
both NF155 (Chang et al., 2000) and gliomedin (Eshed et al.,
2005) are expressed on paranodal loops in addition to their
concentration at axo-glial junctions. Thus interactions between
adjacent closely spaced paranodal loops may also be mediated
by NF either homophilically (Maier et al., 2006) or heterophili-
cally by binding to gliomedin. Interestingly, some paranodalloops in NF null mice appear to have irregularly large inter-loop
spacing (Sherman et al., 2005), consistent with a role for NF155
in this interaction.
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